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Analysis of neointima development in ﬂow diverters
using optical coherence tomography imaging
Yoshikazu Matsuda,1,2 Joonho Chung,1,3 Demetrius K Lopes1
ABSTRACT
Background Flow diverters are used for the treatment
of intracranial aneurysms. Surface modiﬁcation may
decrease the thrombogenicity of ﬂow diverters but the
details are unknown. Optical coherence tomography
(OCT) is an intravascular imaging test with high
resolution which identiﬁes neointimal growth over stents.
We compared the development of neointima in a ﬂow
diverter and stents with and without surface modiﬁcation
in a swine model.
Methods In this study we implanted four devices (two
in each carotid artery) in four pigs. The devices used
were the Pipeline Flex embolization device (PED Flex,
n=6), PED with Shield technology (PED Shield, n=6),
and Solitaire AB (n=4). Serial carotid angiographic and
OCT images were obtained on days 0, 7, 14, and 21.
The data analyzed included: neointimal area (lumen area
− stent area), neointimal ratio ([lumen area − stent
area]/stent area), and the neointimal thickness ratio
(minimum neointimal thickness/maximum neointimal
thickness).
Results There was no signiﬁcant difference in where
neointima formation was initiated in relation to the
implanted device (distal vs middle vs proximal). The PED
Shield had a trend towards earlier endothelial formation
at day 7. By day 21 the neointimal ratio was signiﬁcantly
higher for the PED Flex and PED Shield devices than for
Solitaire (p<0.05 and p<0.01, respectively). The
neointimal thickness ratio was signiﬁcantly higher with
PED Shield than with PED Flex and Solitaire (p<0.05
and p<0.01, respectively).
Conclusions OCT enabled us to follow and compare in
vivo the development of neointima over implants. PED
Shield showed a similar neointimal volume to PED Flex
and more concentric neointima.
INTRODUCTION
Flow diverters and the combination of stents and
coils are commonly used for the repair of wide-necked
intracranial aneurysms. Thromboembolic events are
still one of the most common complications during
endovascular interventions.1–3 Although the causes of
thromboembolism are multifactorial, surface modiﬁ-
cation of the currently available Pipeline Flex
embolization device (PED Flex; Medtronic, Irvine,
California, USA) may reduce the thrombogenicity
of this device. The new PED Flex device with
surface modiﬁcation is called PED with Shield tech-
nology (PED Shield) (Medtronic). The surface
modiﬁcation involves the incorporation of phos-
phorylcholine (PC) into the composition of the ﬂow
diverter. Previous experience with surface modiﬁca-
tion of coronary stents demonstrated no adverse
effect on re-endothelialization with a decrease in the
rate of stent thrombosis.4–7 Recently, one ex vivo
study and one case report with single antiplatelet
therapy using the PED Shield stent have been
reported.8 9
Optical coherence tomography (OCT) is an
intravascular imaging technology with resolution
capable of identifying neointimal growth over
implanted intravascular devices. A number of
reports have validated the correlation of OCT
imaging and histology of the coronary arteries.10 11
There have been no reports of
re-endothelialization assessed by OCT imaging or
histology with the PED Shield stent, although a
previous study reported less thrombogenicity for
this stent in vitro.12
The purpose of this study is to compare the dif-
ference in endothelialization between the PED Flex
and Shield devices using OCT imaging under single
antiplatelet therapy.
METHODS
Animal study design
The study protocol was approved by the local insti-
tutional animal care and use committee. All animals
received humane care in compliance with the
Animal Welfare Act and the ‘Guide for the Care
and Use of Laboratory Animals’ formulated by the
Institute of Laboratory Animal Research (National
Research Press, 1996).
Procedural description
Six PED Flex devices, six PED Shield devices, and
four Solitaire AB devices were implanted in the
carotid arteries (two stents per vessel) of four
Yorkshire pigs weighing 25–35 kg. The size of the
implanted devices was 5×20 mm for PEDs and
4.0×20 mm for Solitaire AB. Three days before the
endovascular procedure the animals were given
10 mg/kg of aspirin. Thereafter, aspirin was admi-
nistered daily throughout the study. Our original
protocol planned to use single antiplatelet therapy
in all animals throughout the study. However, the
ﬁrst angiographic follow-up demonstrated a high
rate of stent thrombosis so we decided to amend
the protocol and start dual antiplatelet therapy.
Clopidogrel 10 mg/kg was administered in all
animals from day 8 after stent implantation. All
thrombosed devices underwent successful recanali-
zation after mechanical thrombectomy with aspir-
ation and angioplasty with non-compliant balloons.
Follow-up angiography showed no further implant
thrombosis. During the study we performed
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intravascular images with OCT and angiography at four time
points (days 0, 7, 14, and 21).
All animals were pre-anesthetized with a mixture of telazol
and xylazine weight-based. After reaching an adequate anes-
thetic status, the animals were intubated and maintained with
continuous inhalation of isoﬂurane (1–3%). A vascular access
sheath (6 F) was percutaneously inserted into the femoral artery.
After sheath insertion, heparin (3000–8000 U) was given
through the sheath. Baseline angiography was acquired and two
stents were implanted in each of the carotid arteries.
OCT imaging protocol and analysis
OCT images were obtained using the Dragon ﬂy Optis imaging
system (LightLab Imaging, St Jude Medical, St Paul, Minnesota,
USA). A motorized OCT catheter pull-back at a rate of
18.0 mm/s while a simultaneous IA iodine contrast injection at a
rate of 4–6 mL/s for a total volume of 16–24 mL to clear the
blood from the vessel were used to obtain all OCT images at
180 frames/s. Ofﬂine OCT image analysis was performed with
Ilumien Optis post-processing software. We selected three cross-
sectional images per pull-back (proximal stent, mid-stent, and
distal stent) for each of the time points of the study. An auto-
mated contour detection algorithm was used for carotid artery
quantiﬁcation. The endoluminal surface was automatically
detected. Stent struts were manually traced and positioned in
the center of the stent strut which showed a bright ‘blooming’
appearance (ﬁgure 1).13 OCT images were excluded from the
analysis if the stent struts and lumen contour were not visible.
The following parameters were measured (ﬁgure 1): lumen
area (deﬁned as contours of the vessel lumen), stent area (identi-
ﬁed by circumferential area limited by the contours of the
struts), neointimal area (stent area − lumen area), neointimal
ratio ([mean stent area − mean lumen area]/mean stent area),
and thickness ratio (minimum neointimal thickness/maximum
neointimal thickness). The neointimal ratio could show the
volume of neointimal formation and also restenosis. A higher
ratio means more neointimal formation. The thickness ratio
could reﬂect the concentricity of neointimal formation: it repre-
sents more concentric neointima formation when the ratio is
close to 1 and eccentric neointima formation when the ratio is
close to 0. To analyze neointimal thickness, the distance
between the center of each stent and the luminal border was
measured in the direction of the center of gravity. Maximum
and minimum thicknesses were automatically calculated.
Malapposition was deﬁned as detachment from the vessel wall,
considering stent strut thickness and blooming artifact of each
type of stent. A total of 192 OCT images on days 0, 7, 14, and
21 were analyzed. Six OCT images were excluded because of
poor images.
Tissue harvesting and histology
Under anesthesia, all animals were euthanized immediately after
the last follow-up imaging (day 21). The carotid arteries were
excised and the stented carotid artery segments were harvested.
After histological processing, the distal edge of the stent was
marked. Three sections were chosen and correlated to OCT
imaging at equidistance from the distal end of the stent. The spe-
cimens were post-ﬁxed in 2.5% glutaraldehyde for a minimum of
2 hours. The slides created using the EXAKT system were stained
with H&E.
A total of 48 OCT images on day 21 and histology-matched
cross-sections were analyzed.
Statistical analysis
Statistical analysis was performed using an add-in statistical ana-
lysis software Statcel V.3 (OMS Publishing Inc, Tokyo, Japan)
for Microsoft Excel (Microsoft, Seattle, Washington, USA). The
Student t-test, Fisher’s exact test, two-way repeated measures
analysis of variance (ANOVA), and one-way ANOVA were used
for statistical comparisons. Tukey post hoc analysis was used.
A p value of <0.05 was considered statistically signiﬁcant.
Figure 1 Automatic contour
detection algorithm for carotid artery
quantiﬁcation. The endoluminal
surface indicated by a green circle was
automatically detected. Stent struts
were manually traced and positioned
in the center of the stent strut. The
lumen, stent, and neointimal (stent −
lumen) area were measured. Maximum
and minimum thickness on
magniﬁcation was automatically
measured (black and white arrows).
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Table 1 Results of OCT analysis in each stent
PED Flex PED Shield Solitaire
Implanted stents, n 6 6 4
Thrombosed stents on day 7, n 6 2 0
Position-based analysis n=18 n=18 n=12
Day 0 Day 7 Day 14 Day 21 Day 0 Day 7 Day 14 Day 21 Day 0 Day 7 Day 14 Day 21
Lumen area, mm2* 16.53±2.12 9.67±3.50 11.12±4.12 10.09±3.87 15.68±1.02 10.01±2.73 9.15±3.98 8.99±4.01 12.68±4.78 8.47±3.88 8.69±2.38 8.82±2.53
Mean diameter, mm* 4.57±0.31 3.42±0.65 3.69±0.72 3.52±0.69 4.47±0.15 3.52±0.52 3.33±0.68 3.31±0.76 3.94±0.78 3.21±0.71 3.30±0.43 3.07±0.93
Stent area, mm2 15.95±1.99 13.51±3.55 13.38±4.1 12.13±4.54 12.12±2.80 12.12±2.80 11.42±4.86 11.71±5.58 8.86±3.74 8.87±3.74 9.23±1.88 9.30±1.79
Mean diameter, mm 4.50±0.29 3.89±0.92 4.08±0.63 3.86±0.74 4.38±0.18 3.90±0.43 3.74±0.76 3.76±0.91 3.79±0.65 3.29±0.67 3.41±0.35 3.42±0.34
Neointima, mm2
(stent − lumen)
3.84±3.02 2.26±1.37 2.04±1.73 2.11±3.36 2.26±2.23 2.72±2.06 0.40±0.39 0.54±0.93 0.48±1.22
Neointimal ratio
([stent − lumen]/stent)
0.16±0.11 0.21±0.096 0.064±0.12
Neointimal thickness minimum, mm 0.039±0.04 0.077±0.071 0.0042±0.012
Neointimal thickness maximum, mm 0.39±0.31 0.45±0.33 0.26±0.16
Thickness ratio
(min/max)
0.1±0.12 0.21±0.17 0.022±0.068
Detected neointima in every position, % 27.8 68.8 100.0 47.1 80.0 100.0 8.3 83.3 100.0
Distal position, % 33.3 80.0 100.0 50.0 100.0 100.0 0.0 75.0 100.0
Middle position, % 16.7 50.0 100.0 33.3 80.0 100.0 25.0 75.0 100.0
Proximal position, % 33.3 80.0 100.0 60.0 60.0 100.0 0.0 100.0 100.0
Data are reported as mean±SD.
*p<0.05 PED Flex vs Solitaire stent.
OCT, optical coherence tomography; PED, Pipeline Flex embolization device.
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RESULTS
Table 1 and ﬁgure 2A describe the neointima development for
each stent during the study. The rate of neointima development
for the PED Flex, PED Shield, and Solitaire devices on day 7
was 5/18 (27.8%), 8/17 (47.1%), and 1/12 (8.3%), respectively.
On day 14, the rates were 11/16 (68.8%), 12/15 (80%), and
10/12 (80%), respectively. On day 21 all devices had complete
neointima coverage.
OCT was used to monitor whether, over time, neointima
developed from the edges (proximal or distal) or from the
centre (middle) of the implanted devices. We found that neoin-
tima coverage of the devices did not follow a predictable pattern
of development (table 1, ﬁgure 2B–D).
The neointimal ratio was signiﬁcantly higher in the PED Flex
and PED Shield groups than in the Solitaire group on day 21
(p<0.05 and p<0.01, respectively). There was no difference
between the PED Flex and PED Shield groups (ﬁgure 3A). The
neointimal thickness ratio on day 21 was signiﬁcantly higher in
the PED Shield group than in the PED Flex and Solitaire groups
(p<0.05, p<0.01; ﬁgure 3B).
OCT images correlated precisely with histopathological pre-
parations, as shown in ﬁgure 4. PED Flex demonstrated asym-
metrical neointima (ﬁgure 4A, D). The histopathological
ﬁndings correlation shows neointima covered above mineraliza-
tion. The Solitaire stent also had an asymmetrical neointima
development (ﬁgure 4C, F) while the PED Shield had more
symmetrical neointima growth (ﬁgure 4B, E).
The mean lumen diameter of the carotid artery on angiog-
raphy before deployment of the PED Flex, PED Shield, and
Solitaire stents was 4.58±0.39 mm, 4.40±0.22 mm, and 4.61
±0.32 mm, respectively. The mean lumen diameter of the
carotid artery in these three groups on OCT imaging after
deployment of the stent was 4.57±0.31 mm, 4.47±0.15 mm,
and 3.94±0.78 mm, respectively. The lumen diameter in the
Solitaire group showed a signiﬁcant reduction after deployment
of the stent (p=0.012). A possible reason is that spasm may
have occurred when the Solitaire stent was deployed.
During the acute phase after device implantation in pigs
taking single antiplatelet therapy (aspirin) there were 8/16
thrombosed devices (6/6 PED Flex, 2/6 PED Shield). The PED
Flex group had signiﬁcantly more thrombosed devices than the
PED Shield and Solitaire stent groups (p<0.05 and p<0.05,
respectively). No further thrombosed devices were seen after
instituting dual antiplatelet therapy.
DISCUSSION
This study illustrates a novel method of comparing the tissue
response (healing) of intravascular implants. The use of OCT
intravascular imaging allowed us to follow and compare in vivo
the development of neointima over implants with different
characteristics. The impact on device ‘healing’ of surface modiﬁ-
cation of ﬂow diverters with PC polymer is unknown.
A previous study reported no adverse effect on the rate of
re-endothelialization in coronary stents, although theoretically
the PC-coated stent might induce a reduction in the rate of
re-endothelialization because of inhibition of deposition of
plasma protein onto the stent strut.5 14 Our result was similar to
this report. The percentage of neointimal formation each week
in the PED Shield group was not signiﬁcantly different from the
PED Flex group (ﬁgure 2A), although the PED Shield group
showed a tendency towards a higher percentage of neointimal
formation than the PED Flex group. Although the mechanism
for the effect of PC coating on wound healing and neointimal
formation was unknown in previous reports,5 we hypothesize
that PC coating on the PED Shield device might result in an
earlier healing response because PC could shorten a few early
Figure 2 (A) Percentage neointimal formation by location over time did not differ signiﬁcantly between stents. (B) Percentage neointimal
formation of the Pipeline Flex embolization device (PED Flex) divided into distal, middle, and proximal portions. (C) Percentage neointimal formation
of the PED Shield device in each position. (D) Percentage neointimal formation of the Solitaire device in each position. Each stent shows no
difference between the three positions. Bars are +SEs.
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steps of neointima formation. On the other hand, the neointi-
mal ratio in the PED Flex and PED Shield groups was signiﬁ-
cantly higher than in the Solitaire group. We suggest that this
difference in the effect on neointimal formation was due to the
fact that there are more stent struts in ﬂow diverters than in the
Solitaire device, resulting in more ‘support’ for the development
of the neointima. Darsaut et al reported that aneurysm occlu-
sion was associated with neointimal closure of the ﬂow diverter
pores and the amount of metal surface coverage over the aneur-
ysm ostium.15 Our study shows that ﬂow diverters (PED Flex
and PED Shield) have earlier as well as thicker neointimal for-
mation than ﬂexible stents (Solitaire). This result illustrates why
ﬂow diverters induce more durable aneurysmal occlusion than
intracranial ﬂexible stents. Surface modiﬁcation with PC may be
an independent factor on neointima development since we
observed that the thickness ratio in the PED Shield group was
signiﬁcantly higher than in the PED Flex and Solitaire groups.
Shibuya et al16 reported that eccentric and heterogeneous
neointima formation in coronary stents assessed by OCT could
signal late neointimal hyperplasia. The OCT images in the PED
Flex group showed an eccentric and heterogeneous growth
pattern while the PED Shield had a concentric and homoge-
neous neointimal pattern of growth. In our study the PED Flex
was associated with more thrombus formation on the struts.
The histology revealed that the neointima developed over the
thrombus on the struts, perhaps resulting in the eccentric and
heterogeneous pattern seen in the PED Flex group. Figure 4A,
D shows the thrombus on the stent struts covered by neointima
(also described as mineralization). The effect of PC surface
modiﬁcation might result in less thrombus and a more concen-
tric neointima formation resulting in less late neointimal hyper-
plasia and reducing in-stent stenosis rates.
A few histological reports have shown that the initiation of
neointimal formation for implanted coronary bare metal stents
in pigs is 7 or 14 days.17–20 Many studies also showed a correl-
ation between OCT imaging and histological evaluation.10 11
Virmani et al reported surface endothelialization of >70% at 7
days. In this study the initiation of neointimal formation on the
devices studied using OCT imaging was demonstrated by day 7
(ﬁgure 2). However, the endothelialization rate was different
between the Solitaire stent and bare metal stents in a previous
report. The difference between OCT imaging and histopath-
ology might be one possible reason. OCT imaging may not be
detectable if neointima on the surface of the stent is very thin,
especially <10 mm.
We divided the implants into three sections (distal, middle
and proximal) and evaluated where neointima formation was
initiated in each section (ﬁgure 2). No signiﬁcant difference was
found between the three positions. de Prado et al17 and
Virmani et al18 reported that the inﬂammatory reaction
Figure 4 Representative optical
coherence tomography (OCT) images
and upper part of the histopathological
ﬁndings divided longitudinally in each
stent. (A) Asymmetrical neointima in
the Pipeline Flex embolization device
(PED Flex). Black arrow shows
neointima covering mineralization. (B)
Symmetrical neointima in the PED
Shield stent (black arrows). (C)
Asymmetrical neointima and less stent
strut in Solitaire stent. (D) OCT image
of asymmetrical and heterogeneous
neointima in the PED Flex stent. White
arrow shows neointima covering low
back scattering lesion. (E) OCT image
of symmetrical and homogenous
neointima in the PED Shield stent
(white arrows). (F) OCT image of
asymmetrical and homogeneous
neointima in the Solitaire stent.
Figure 3 (A) Neointimal ratio on day 21 in each stent. The Pipeline
Flex embolization device (PED Flex) and PED Shield stent had a
signiﬁcantly higher neointimal ratio than the Solitaire stent (p<0.01
and p<0.05, respectively). There is no difference between the PED
Shield and PED Flex. (B) Neointimal thickness ratio on day 21 in each
stent. The PED Shield stent shows a signiﬁcantly higher neointimal
thickness ratio than the PED Flex and Solitaire stents (p<0.05 and
p<0.01, respectively). There is no difference between the PED Flex and
Solitaire stents. Bars are +SEs.
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containing ﬁbrin and platelets or macrophages around stent
struts were factors for initiation of neointimal formation.
Furthermore, de Prado et al17 reported that no signiﬁcant differ-
ences were detected although the endothelialization of the stent
struts at the edges (both proximal and distal) seemed to be
better than in the middle part of the coronary stent. We
observed a tendency for better neointima formation in the PED
Shield and PED Flex groups at both the distal and proximal
ends of the stent compared with the middle of the stent, but
this ﬁnding was not statistically signiﬁcant (ﬁgure 2B, C). We
concluded that neointimal formation starts at random sites
within the implanted device.
This study had several limitations. We performed mechanical
thrombectomy for thrombosed devices. Any intravascular
manipulation before or after device implantation can damage
the initial endothelial coverage. As a result, this manipulation
might lead to misinterpretation of the extent of ﬁnal tissue
coverage. Although a recent animal study suggests that mechan-
ical thrombectomy with aspiration alone did not cause endothe-
lial damage,21 angioplasty can result in full de-endothelialization
of the vessels.22 23 Another limitation is that six PED Flex and
two PED Shield vessels thrombosed at day 7, resulting in an
even further effect from interaction of the clot with the vessel
wall. This biological effect can alter the process of neointimal
formation. The results of our study should be interpreted in
light of the limitations of our porcine model. All the treated
vessels were straight and without aneurysms or branches.
This model does not evaluate some of the hemodynamic forces
and challenges of aneurysm neck healing seen in clinical
situations.
CONCLUSION
This study illustrates a novel method of comparing the tissue
response (healing) of intravascular implants. The use of OCT
intravascular imaging allowed us to follow and compare in vivo
the development of neointima over implants with different
characteristics. The PED Shield device showed a tendency for
earlier neointimal formation. The volume of neointimal forma-
tion for the PED Shield stent on day 21 was not signiﬁcantly
different from that for the PED Flex. However, the PED Shield
showed more evenly distributed concentric neointimal forma-
tion than the other devices. The pattern of neointima formation
over an implant is random.
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